Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety ... Precision BiosciencesFebruary 19, 2021 GMT DURHAM, N.C., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage biotechnology company, today announced the publication of a paper in Molecular Therapy describing three-year follow-up data showing long-term stable reduction of low-density lipoprotein (LDL) cholesterol levels in nonhuman primates (NHPs) following in v...
Source: apnews.com